openPR Logo
Press release

Growth Postmenopausal Osteoporosis Therapeutics Market: 2015 - 2021

02-22-2017 02:31 PM CET | Health & Medicine

Press release from: Persistence Market Research Pvt. Ltd

Growth Postmenopausal Osteoporosis Therapeutics Market: 2015

Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related diseases worldwide and also represents a major public health problem. Osteoporosis is common among females than in the male population. Women with age more than 50 years are more prone to osteoporosis due to hormonal changes occurring after menopause. The currently available technologies fail to cure postmenopausal osteoporosis completely and thus healthcare professionals prefer medicinal therapy for treatment of postmenopausal osteoporosis.

A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/5882

Considering the relation of age in postmenopausal osteoporosis, aging of population worldwide is the major factor that is increasing the morbidity rate of postmenopausal osteoporosis. Increasing prevalence of this condition and innovations in the corresponding drug market are major driving forces of the postmenopausal osteoporosis therapeutics market. While high standards for approval of any new product to launch into the market, competition from the emerging alternative technologies and intense competition from generics are restraining growth of this market. Mergers and acquisitions taking place in the market is one of the major restraining force of postmenopausal osteoporosis therapeutics market.

Based on the type of medicines used, postmenopausal osteoporosis therapeutics market is segmented as follows:

Bisphosphonates
Hormones
Strontium ranelate
Raloxifene
Denosumab
Others

Geographically, the global postmenopausal osteoporosis therapeutics market is segmented into:

North America
Europe
Asia Pacific
Rest of the World

Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/5882

Currently, North America dominates the postmenopausal osteoporosis therapeutics market and is closely followed by Europe. Asia-Pacific is a lucrative regional market for such drugs considering factors such as increasing healthcare spending and improving healthcare infrastructure. Gradual; development of the medical tourism industry in the region is also expected to further spur the growth of postmenopausal osteoporosis therapeutics market in Asia-Pacific. Some of the major companies contributing to the global postmenopausal osteoporosis therapeutics market are Eli Lilly, Pfizer, Inc., F. Hoffman La Roche, Procter & Gamble and Merck.

About Us
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated re-search, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Con-sumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s en-gagement models are highly flexible without compromising on its deep-seated research values.

Contact
Persistence Market Research Pvt. Ltd
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Growth Postmenopausal Osteoporosis Therapeutics Market: 2015 - 2021 here

News-ID: 445162 • Views: 183

More Releases from Persistence Market Research Pvt. Ltd

Global HPMC Capsules Market is expected to reach a Valuation of US$ 554.5 Mn Ove …
HPMC capsules are strictly non-toxic and qualify to be Kosher and Halal-certified, which is why their popularity has grown in several parts of the world. Moreover, these capsules can significantly boost the body metabolism by improving absorption and digestion of protein, fat and carbohydrates. HPMC capsules find their application in the preparation of non-animal based medicines and cosmetics & nutraceuticals products. Persistence Market Research (PMR) recently conducted a study
Vacuum Tissue Processor Technology Most Favored in the Global Tissue Processing …
Persistence Market Research has come up with a fact based analytical research study describing various aspects of the tissue processing systems market across the globe. The analysis on tissue processing systems has been systematically drafted in a new research publication titled “Tissue Processing Systems Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025)”. This comprehensive research report focuses on various developments, trends, restraints, opportunities, drivers and challenges impacting revenue growth of
Endodontics Market Is Projected To Grow At A Moderate CAGR During The Period Of …
Endodontics is associated with the dentistry segment. It involves several therapies to protect the human teeth from infections and injuries caused to the dental pulp. Generally, it is concerned with morphology, pathology as well as physiology of dental pulp and the periradicular tissues. Endodontics is important during carrying out root canal procedure in order to reduce the inflammation and to end infection. Modernization has touched the field of endodontics as
Global Home Infusion Therapy Devices Market Driven by Growing Incidence of Pain, …
According to the latest market report published by Persistence Market Research titled ‘Home Infusion Therapy Devices Market: Global Industry Analysis (2012-2016) and Forecast (2017-2025),’ the global Home Infusion Therapy Devices market is expected to expand at a CAGR of 6.8% during the forecast period 2017–2025. Persistence Market Research delivers key insights and presents a revised forecast of the global Home Infusion Therapy Devices market for an eight year period from

All 5 Releases


More Releases for Osteoporosis

2022 Osteoporosis Drugs Market Analysis & Forecast
Global Osteoporosis Drugs Market Information, by drug class (Bisphosphonates, Calcitonins, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone (PTH) and Others), by route of administration (oral, injectable and others) and by gender (male and female) - Forecast to 2022 The Global Osteoporosis Market to reach 14,300 million by 2022, growing with a CAGR of 4.7%. Osteoporosis is weakening of bones due to lower bone mass resulting in and micro-architectural deterioration of bone
Global Osteoporosis Drugs Sales Market Report 2017
Summary: Report Hive Market Research Released a New Research Report of 100 pages on Title " Global Osteoporosis Drugs Sales Market Report 2017 "with detailed Analysis, Forecast and Strategies. Description: In this report, the global Osteoporosis Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global
Datamonitor Healthcare Osteoporosis KOL Interviews
ReportsWorldwide has announced the addition of a new report title Datamonitor Healthcare Osteoporosis KOL Interviews to its growing collection of premium market research reports. For a Detailed description and table of contents of this report please click here: https://www.reportsworldwide.com/report/datamonitor-healthcare-osteoporosis-kol-interviews February 03, 2017 Datamonitor Healthcare interviewed an endocrinologist based in the US and a rheumatologist based in the UK to gauge their views on current treatment options, late stage clinical candidates, treatment challenges
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related
Recent Press Release Updates Global Osteoporosis Market
MarketResearchReports.Biz is providing you Retail Market Research report of "Osteoporosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017". Latest Report, Osteoporosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Osteoporosis Report is to understand the market and pipeline status of the drugs around the Osteoporosis
Global Osteoporosis Drugs Market 2016:Bisphosphonates, Calcitonin
Osteoporosis is a condition in which the bones become weak and fragile due to the loss of tissue. This condition can arise due to hormonal changes, the deficiency of calcium or vitamin. In osteoporosis, the microstructure of bones is changed due to the change in bone mass and bone density. Osteoporosis can cause severe injury or pain and requires timely treatment. Osteoporosis patients find it difficult to comply with the